Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 1,408

Document Document Title
WO/1983/003604A1
Process for preparing substitued polycyclo-alkylidene polycyclo-alkanes, such as substituted adamantylidene adamantanes, and the corresponding epidioxy compounds, in which polycyclo-alkylidene polycyclo-alkanes are halogenated with an N-...  
WO/1983/003099A1
The invention relates to products having the general formula I, wherein R1 is thienyl or phenyl optionally substituted, furyl, cycloalkyl, naphtyl, phenyl-phenyl, alkyl or alkenyl; R2 is methyl or ethyl; R3 is H, OH, alkyl, alkenyl, opti...  
WO/1982/003396A1
Novel cundurango glycoside compounds represented by the following general formula: (FORMULA) process for their preparation from an extract of Marsdenia cundurango Reichenbach fil., use of the compound or composition containing it as an a...  
WO/1982/000465A1
Methods for preparing the various isomeric forms of 25-hydroxyvitamin D3-26, 23-lactone utilizing cyanohydrin formation with readily prepared steroid materials followed by actinic radiation of the products and recovery of the desired 25-...  
WO/1982/000294A1
5(Beta)-hydroxy-(Alpha)6-steroid derivatives having the general formula (FORMULA) wherein R1 represents a hydrogen atom, an acyl, lower alkyl or tetrahydropyranyl residue and R2, R3 each a hydrogen atom or in common a methylene residue a...  
WO/1981/002577A1
Novel cundurango glycosides represented by the following general formula (1), a process for preparing them from an extract of Marsdenia cundurango Reichenbach fil. of potato family, and the use of a compound or composition containing the...  
WO/1981/002298A1
New derivative of vitamin D, 25-hydroxy-26,26,26,27,27,27-hexafluoro cholecalciferol and process for preparing the same. The compound is characterized by vitamin D-like activity in their ability to increase intestinal calcium transport, ...  
WO/1980/002502A1
New vitamin D derivatives as well as new intermediate compounds derived during the processes for preparing such new derivatives. The new derivatives have been identified as 1(Alpha)-hydroxy-25-keto-27-nor-vitamin D3 and its acylates. 1(A...  
JP2020528080A
The present invention indicates a Panaxazi all saponin derivative, its preparing method, and use. Such a compound shows a high antiinflammatory effect in in vitro one and an animal model experiment, and, for this reason, can apply it to ...  
JP2020103223A
[Subject] It aims at providing the new method of manufacturing a cyclo Astra Genol analog from Astra Galo Cyd IV. [Means for Solution] How to manufacture a cyclo Astra Genol analog including a contact process of contacting Astra Galo Cyd...  
JP6661643B2  
JP2020506177A
The present invention provides a new Ergos tenor glycoside derivative. The Ergos tenor and its glycoside derivative of the present invention, In dermatitis prevention and medical treatment, production of the chemokine which increases by ...  
JP2020500198A
The present invention relates to the skeletal muscle hypertrophy inducing agent in the disposal or prevention of a disease or damage which brings about skeletal muscle tissue loss and/, or muscle weakness, and its use in order to promote...  
JP6621217B2  
JP2019533651A
Generally the present invention relates to the constituent and method for dealing with cancer and col overThizonosis. In this specification, the replaced steroid derivative compound and the medicine constituent containing the replaced st...  
JP2019532079A
Formula (A) : Of compound , its salt which can be received pharmacologically, and its pharmacological constituent are provided, and they are inside of a formula, and R.1R2R3R4R5R6And RGIt is as defining in Is and this specification. The ...  
JP2019529550A
The Panax diol type Ginsenoside derivative which has the structure shown in formula I or formula II is provided. Those use in manufacture of the medicine for preventing and treating atheroma Disease is also provided. The above-mentioned ...  
JP2019520416A
Neuroactive steroid or its salt which can be received pharmacologically is indicated in this specification. It is assumed that such a compound acts as a GABA regulation factor in a specific embodiment. The directions for use and the trea...  
JPWO2018016483A1
A Mogrol glycoside and the new manufacturing method of Mogrol were called for. The present invention provides a Mogrol glycoside including the process of cutting at least one glucosidic linkage of a Mogrol glycoside, and/or the manufactu...  
JP2019516720A
The present invention is a compound of general formula (I) : [Formula 1](Inside of a formula: R)1R2R3R4R5R6And Y is as being defined as this specification, and is related for being. The compound is an intermediate in composition of usefu...  
JP2019068741A
To provide algae that produce sterol, and a method for producing sterol using the same.Algae such as AJ7867 strain (FERM P-22304) and a strain derived therefrom, having a sterol production ability, are cultured. From bodies of the result...  
JP2019510051A
Formula (I) :They are [in / the compound boiled and twisted, its salt which can be received pharmacologically, and its pharmacological constituent are provided, and /; type (I) ] A and R.1And R5It is as defining in Is and this specificat...  
JP2019500374A
Generally the present invention relates to a constituent and a method for dealing with cancer and col over Tizons disease . A medicine constituent containing a replaced steroid derivative compound and the above-mentioned compound is prov...  
JP2018519328A
Formula (I)It is alike, the compound of a statement, its salt which can be received pharmacologically, and its pharmacological constituent are provided, and they are inside of; type, and R.1R2And R5It is as defining in Is and this specif...  
JP6270823B2  
JP2017536379A
The present invention provides the directions for these compounds for preventing or treating a disease or condition of disease of a compound of an amino substitution bile acid derivative, a medicine constituent containing these compounds...  
JP2017535586A
Formula (II) : They are [in / are The nerve stimulus sex steroid or its salt which can be received pharmacologically, and / formula (II) ] :A and R.1R2aR2bR3aR3bR4aR4bR5R6It reaches. The neuroactive steroid which is as defining in Is and...  
JP2017530174A
A method and a constituent are provided for prevention of the condition relevant to the lipid accumulation obstacle caused by the leptin activity and the lipid accumulation obstacle which decreased, and/or disposal. This method includes ...  
JP2017530194A
It is related with the present invention treating HBV or HDV infection with the medicine constituent containing polymerization bile acid or its salt and polymerization bile acid or its salt and HBV of the second sort, or HDV medicine, or...  
JP2017521459A
The present invention relates to the method for preparing the new steroid compound of formula (I), and it, and the constituent containing these compounds. [Formula 1]  
JP2017516851A
The present invention relates to a compound and its therapeutic use, especially the use for improving the quality of the muscles in a mammal. In detail, the present invention can improve the quality of the muscles in the mammal of sarcop...  
JP2017019845A5  
JP2016155834A
To provide a photochromic compound and a composition.Compounds generally containing an indeno[2',3':3,4]naphtho[1,2-b]pyran structure are described in this invention. The compounds can be useful for their photochromic characteristics and...  
JP2016041770A
To provide methods and compositions for increasing telomerase activity in cells.Such compositions include pharmaceuticals, including topical and nutraceutical formulations. The methods and compositions are useful for treating diseases re...  
JP2016508489A
The present invention provides the protopanaxadiol derivative denoted by structural formula I or II, manufacturing method, and application. The present invention embellished the structure of protopanaxadiol and obtained a plurality of ne...  
JP2016505038A
The compound and constituent of 11beta* hydroxy steroid with the new present invention, And medical supplies for preventing or reversing damage to the mitochondria in humans or an animal object, Those application as medical supplies for ...  
JP2016501840A
The constituent containing E* selectin antagonist medical treatment agent, improvements of this, and these E* selectin antagonists is provided in this specification. In order to deal with and/or prevent the disease and obstacle with whic...  
JP5809470B2  
JP2015520146A
The present invention relates to the use for treating malignant blood dyscrasia in order to treat the disease related to a new sterol derivative, its manufacturing method, the medicine constituent containing it, and the transformed astro...  
JP5712546B2  
JP2015511608A
Ginsenoside C*K many forms and a manufacturing method for the same are provided. Ginsenoside C*K many forms are crystal form D and crystal form H.  
JP2015511607A
Several kinds of ギンセノシド many 形物 and a preparing method for the same are provided. In particular, it is related with new crystal form A, crystal form B, crystal form C, crystal form E, crystal form F, crystal form I, cryst...  
JP5701308B2  
JP2014177482A
To provide a novel process for preparing a compound of the formula (I).A process comprises converting 6-alpha,9-alpha-difluoro-17-alpha-[(2-furanyl carbonyl)oxy]-11-beta-hydroxy-16-alpha-methyl-3-oxo-androsta -1,4-diene-17-beta-carbothio...  
JP5583882B2  
JP5568299B2  
JP5563285B2  
JP5546851B2  
JP5524971B2  
JP5516908B2  

Matches 351 - 400 out of 1,408